Ion Beam Applications SA (IOBCF)
USD 14.05
(0.0%)
USD 14.05
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 597.52 Million EUR | -4.23% |
| 2022 | 623.89 Million EUR | 14.26% |
| 2021 | 546.05 Million EUR | 6.86% |
| 2020 | 510.99 Million EUR | 20.2% |
| 2019 | 425.11 Million EUR | 8.41% |
| 2018 | 392.12 Million EUR | 17.93% |
| 2017 | 332.51 Million EUR | -12.64% |
| 2016 | 380.61 Million EUR | -3.73% |
| 2015 | 395.35 Million EUR | 28.76% |
| 2014 | 307.05 Million EUR | 8.98% |
| 2013 | 281.75 Million EUR | -27.04% |
| 2012 | 386.19 Million EUR | -22.45% |
| 2011 | 498.01 Million EUR | -5.72% |
| 2010 | 528.2 Million EUR | 10.13% |
| 2009 | 479.64 Million EUR | -5.86% |
| 2008 | 509.52 Million EUR | 57.05% |
| 2007 | 324.43 Million EUR | 21.57% |
| 2006 | 266.86 Million EUR | 31.62% |
| 2005 | 202.75 Million EUR | -41.27% |
| 2004 | 345.21 Million EUR | -31.03% |
| 2003 | 500.56 Million EUR | -27.47% |
| 2002 | 690.15 Million EUR | -9.72% |
| 2001 | 764.47 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 596.15 Million EUR | 0.0% |
| 2024 Q1 | 596.15 Million EUR | -0.23% |
| 2023 Q3 | 597.52 Million EUR | -2.08% |
| 2023 Q2 | 610.24 Million EUR | 0.0% |
| 2023 Q1 | 610.24 Million EUR | -2.19% |
| 2023 Q4 | 597.52 Million EUR | 0.0% |
| 2023 FY | 597.52 Million EUR | -4.23% |
| 2022 Q1 | 550.05 Million EUR | 0.73% |
| 2022 Q4 | 623.89 Million EUR | 0.0% |
| 2022 FY | 623.89 Million EUR | 14.26% |
| 2022 Q3 | 623.89 Million EUR | 13.43% |
| 2022 Q2 | 550.05 Million EUR | 0.0% |
| 2021 Q4 | 546.05 Million EUR | 0.0% |
| 2021 Q3 | 546.05 Million EUR | 11.64% |
| 2021 Q1 | 489.12 Million EUR | -4.28% |
| 2021 FY | 546.05 Million EUR | 6.86% |
| 2021 Q2 | 489.12 Million EUR | 0.0% |
| 2020 Q1 | 440.9 Million EUR | 3.72% |
| 2020 Q2 | 440.9 Million EUR | 0.0% |
| 2020 Q3 | 510.99 Million EUR | 15.9% |
| 2020 Q4 | 510.99 Million EUR | 0.0% |
| 2020 FY | 510.99 Million EUR | 20.2% |
| 2019 FY | 425.11 Million EUR | 8.41% |
| 2019 Q4 | 425.11 Million EUR | 0.0% |
| 2019 Q1 | 392.33 Million EUR | 0.05% |
| 2019 Q3 | 425.11 Million EUR | 8.35% |
| 2019 Q2 | 392.33 Million EUR | 0.0% |
| 2018 Q1 | 358.49 Million EUR | 7.81% |
| 2018 FY | 392.12 Million EUR | 17.93% |
| 2018 Q4 | 392.12 Million EUR | -3.71% |
| 2018 Q3 | 407.24 Million EUR | 13.6% |
| 2018 Q2 | 358.49 Million EUR | 0.0% |
| 2017 Q3 | 332.51 Million EUR | -8.4% |
| 2017 Q2 | 363 Million EUR | 0.0% |
| 2017 Q1 | 363 Million EUR | -4.63% |
| 2017 Q4 | 332.51 Million EUR | 0.0% |
| 2017 FY | 332.51 Million EUR | -12.64% |
| 2016 Q1 | 371.78 Million EUR | -5.96% |
| 2016 Q3 | 380.61 Million EUR | 2.37% |
| 2016 FY | 380.61 Million EUR | -3.73% |
| 2016 Q2 | 371.78 Million EUR | 0.0% |
| 2016 Q4 | 380.61 Million EUR | 0.0% |
| 2015 Q1 | 328.37 Million EUR | 6.94% |
| 2015 Q4 | 395.35 Million EUR | 0.0% |
| 2015 FY | 395.35 Million EUR | 28.76% |
| 2015 Q2 | 328.37 Million EUR | 0.0% |
| 2015 Q3 | 395.35 Million EUR | 20.4% |
| 2014 Q2 | 298.63 Million EUR | 0.0% |
| 2014 Q3 | 307.05 Million EUR | 2.82% |
| 2014 Q4 | 307.05 Million EUR | 0.0% |
| 2014 Q1 | 298.63 Million EUR | 5.99% |
| 2014 FY | 307.05 Million EUR | 8.98% |
| 2013 FY | 281.75 Million EUR | -27.04% |
| 2013 Q4 | 281.75 Million EUR | 0.0% |
| 2013 Q3 | 281.75 Million EUR | -15.91% |
| 2013 Q2 | 335.06 Million EUR | 0.0% |
| 2013 Q1 | 335.06 Million EUR | -13.24% |
| 2012 FY | 386.19 Million EUR | -22.45% |
| 2012 Q4 | 386.19 Million EUR | 0.0% |
| 2012 Q3 | 386.19 Million EUR | -6.55% |
| 2012 Q2 | 413.27 Million EUR | 0.0% |
| 2011 Q2 | 567.76 Million EUR | 0.0% |
| 2011 FY | 498.01 Million EUR | -5.72% |
| 2011 Q4 | 498.01 Million EUR | 0.0% |
| 2010 FY | 528.2 Million EUR | 10.13% |
| 2010 Q4 | 528.2 Million EUR | 0.0% |
| 2010 Q2 | 533.98 Million EUR | 0.0% |
| 2009 Q4 | 479.64 Million EUR | 0.0% |
| 2009 FY | 479.64 Million EUR | -5.86% |
| 2008 FY | 509.52 Million EUR | 57.05% |
| 2007 FY | 324.43 Million EUR | 21.57% |
| 2006 FY | 266.86 Million EUR | 31.62% |
| 2005 FY | 202.75 Million EUR | -41.27% |
| 2004 FY | 345.21 Million EUR | -31.03% |
| 2003 FY | 500.56 Million EUR | -27.47% |
| 2002 FY | 690.15 Million EUR | -9.72% |
| 2001 FY | 764.47 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AVITA Medical, Inc. | 144.33 Million USD | -313.973% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -188991.139% |
| Össur hf. | 1.39 Billion USD | 57.13% |
| QHSLab, Inc. | 1.68 Million USD | -35436.852% |
| Wellstar International, Inc. | 957.89 Thousand USD | -62279.475% |
| Össur hf. | 1.39 Billion USD | 57.13% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 4.75 Million USD | -12458.584% |
| Aurora Spine Corporation | 11.92 Million USD | -4911.24% |
| BrainsWay Ltd. | 62.97 Million USD | -848.879% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 144.38 Thousand USD | -413734.945% |
| Hamilton Thorne Ltd. | 110.16 Million USD | -442.401% |
| Vivos Inc. | 1.61 Million USD | -37010.682% |
| Kelyniam Global, Inc. | 1.63 Million USD | -36497.672% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -49433.372% |
| Zecotek Photonics Inc. | 2.57 Million USD | -23123.974% |
| Avitar, Inc. | 1.74 Million USD | -34086.947% |
| Nanomix Corporation | 982.05 Thousand USD | -60744.657% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | -480.571% |
| Theraclion SA | 18.66 Million EUR | -3101.574% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.76 Million USD | -33703.524% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -79742.541% |
| Lombard Medical, Inc. | 67.76 Million USD | -781.739% |
| ALR Technologies Inc. | 193.21 Thousand USD | -309152.291% |
| Stratec SE | 529.71 Million USD | -12.802% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -60116.588% |
| Heart Tronics, Inc. | 4.04 Million USD | -14657.655% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 84.801% |
| VMS Rehab Systems, Inc. | 4.45 USD | -13427595405.618% |
| NewCardio, Inc. | 2.85 Million USD | -20843.452% |
| Guided Therapeutics, Inc. | 1.66 Million USD | -35701.558% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -80894.608% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -130996.353% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -1091315.212% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -327887.704% |
| SANUWAVE Health, Inc. | 22.41 Million USD | -2565.632% |
| IR-Med Inc. | 999 Thousand USD | -59712.613% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | -2808.9% |
| Polarean Imaging plc | 10.86 Million USD | -5398.421% |
| United American Healthcare Corporation | 10.37 Million USD | -5657.086% |
| ECGI Holdings, Inc. | 5.2 Million USD | -11387.813% |
| Nu-Med Plus, Inc. | 2.21 Million USD | -26912.592% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -1768048.192% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | -27838.476% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -68520.567% |
| Urologix, Inc. | 5.66 Million USD | -10443.992% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | -26402.852% |
| Nexeon MedSystems Inc. | 20.35 Million USD | -2836.047% |
| SS Innovations International, Inc. | 25.47 Million USD | -2245.17% |
| Qualis Innovations, Inc. | 2431.00 USD | -24579414.603% |
| Smith & Nephew plc | 9.97 Billion USD | 94.008% |
| NIOX Group Plc | 116.47 Million USD | -412.99% |
| Fuse Medical, Inc. | 16.25 Million USD | -3575.021% |
| Broncus Holding Corporation | 195.75 Million USD | -205.248% |
| Brain Scientific Inc. | 11.74 Million USD | -4988.105% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -56824.994% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -2079343.188% |